 WIXOM, Mich. , May 23, 2022 PRNewswire -- Rockwell Medical, Inc. Nasdaq: RMTI Rockwell Medical or the Company, a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management, today announced that Russell Ellison, M.D. 